MedPath

江苏加友药业集团有限公司

Ownership
-
Established
2021-06-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Oseltamivir Phosphate For Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253775
Approval Date
Apr 1, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.